Yan Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yan Zhang has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
Lihua Huang
Department of Pediatric Surgery, Clinical and Research Center for Hirschsprung Disease, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangdong Provincial Children's Medical Research Center, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China
5 shared publicationsXiaoyu Zuo
Department of Pediatric Surgery, Clinical and Research Center for Hirschsprung Disease, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangdong Provincial Children's Medical Research Center, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China
5 shared publicationsYun Zhu
Department of Pediatric Surgery, Clinical and Research Center for Hirschsprung Disease, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangdong Provincial Children's Medical Research Center, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China
5 shared publicationsChaoting Lan
Provincial Key Laboratory of Research in Structure Birth Defect Disease and Department of Pediatric Surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623 Guangdong, China
4 shared publications- Huimin Xia
Provincial Key Laboratory of Research in Structure Birth Defect Disease and Department of Pediatric Surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623, Guangdong, China
4 shared publications Jiazhang Chen
Department of Pediatric Surgery, Clinical and Research Center for Hirschsprung Disease, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangdong Provincial Children's Medical Research Center, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China
4 shared publications
Latest Publications
- 5 June 2026
- Published by Elsevier in Gastroenterology
- Vol. 171 (5) , 919-932
PRDM9 Deficiency Drives Mosaic Promoter Deletions in Sporadic Hirschsprung Disease and Supports Blood-Based Molecular Stratification
- 5 June 2026
- Published by Elsevier in Gastroenterology
- Vol. 171 (5) , 919-932
PRDM9 Deficiency Drives Mosaic Promoter Deletions in Sporadic Hirschsprung Disease and Supports Blood-Based Molecular Stratification
- Open Access
- 1 March 2026
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (2) , 101595
Integrated genomic analysis of EDNRB common and rare variants in Hirschsprung disease
- 1 March 2026
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (2) , 101595
Open AccessIntegrated genomic analysis of EDNRB common and rare variants in Hirschsprung disease
- Open Access
- 15 October 2025
- Published by Elsevier in Journal of Advanced Research
- Vol. 85, 805-818
Exosomes derived from M1-macrophage promote enteric neuronal injury via MMP8-TGF-β pathway
- 15 October 2025
- Published by Elsevier in Journal of Advanced Research
- Vol. 85, 805-818
Open AccessExosomes derived from M1-macrophage promote enteric neuronal injury via MMP8-TGF-β pathway
- Open Access
- 1 October 2025
- Published by Wiley in Animal Models and Experimental Medicine
- Vol. 8 (10) , 1866-1875
Refining the Sox10 Dom/+ mouse model: A new breeding strategy with relevance to Hirschsprung disease genetics
Background: The traditional Sox10 Dom/+ mouse breeding strategy is costly and time‐consuming, so this study aims to optimize the breeding method and improve the scientific research efficiency. Methods: We select the offspring from mating B6C3Fe Sox10 Dom/+ male mice with C57BL/6J female mice, and name the progeny B6C3Fe‐g. Further, conduct separate self‐breeding for both the B6C3Fe and B6C3Fe‐g strains, adhering to the principle of pairing mutants with non‐mutants. By comparing the number of offspring, survival rates, and the phenotype of aganglionosis in the colon, a comprehensive evaluation of their breeding capacity and phenotypic stability is conducted. Results: Sanger sequencing results show that the mutation sites of B6C3Fe and B6C3Fe‐g mice are consistent. After fluorescent staining of intestinal nerves, it was found that the heterozygous mice of the two strains had neuronal deletion in the distal colon, and this pathological phenotype was consistent with the pathological features of the diseased colon of Hirschsprung disease (HSCR). However, compared with the B6C3Fe strain, the B6C3Fe‐g strain has a higher number of offspring and greater survival rates. Conclusions: The breeding strategy of the B6C3Fe‐g strain ensures genetic and phenotypic stability, while improving reproductive efficiency, and is an ideal scheme for breeding Sox10 Dom/+ mice.
- 1 October 2025
- Published by Wiley in Animal Models and Experimental Medicine
- Vol. 8 (10) , 1866-1875
Open AccessRefining the Sox10 Dom/+ mouse model: A new breeding strategy with relevance to Hirschsprung disease genetics
Background: The traditional Sox10 Dom/+ mouse breeding strategy is costly and time‐consuming, so this study aims to optimize the breeding method and improve the scientific research efficiency. Methods: We select the offspring from mating B6C3Fe Sox10 Dom/+ male mice with C57BL/6J female mice, and name the progeny B6C3Fe‐g. Further, conduct separate self‐breeding for both the B6C3Fe and B6C3Fe‐g strains, adhering to the principle of pairing mutants with non‐mutants. By comparing the number of offspring, survival rates, and the phenotype of aganglionosis in the colon, a comprehensive evaluation of their breeding capacity and phenotypic stability is conducted. Results: Sanger sequencing results show that the mutation sites of B6C3Fe and B6C3Fe‐g mice are consistent. After fluorescent staining of intestinal nerves, it was found that the heterozygous mice of the two strains had neuronal deletion in the distal colon, and this pathological phenotype was consistent with the pathological features of the diseased colon of Hirschsprung disease (HSCR). However, compared with the B6C3Fe strain, the B6C3Fe‐g strain has a higher number of offspring and greater survival rates. Conclusions: The breeding strategy of the B6C3Fe‐g strain ensures genetic and phenotypic stability, while improving reproductive efficiency, and is an ideal scheme for breeding Sox10 Dom/+ mice.
- 1 October 2025
- Published by Elsevier in Journal of Hepatology
- Vol. 84 (2) , 370-384
Targeting cell-state plasticity driven by FOXM1/CEBPB axis disrupts developmental heterogeneity and therapeutic resistance in hepatocellular carcinoma
- 1 October 2025
- Published by Elsevier in Journal of Hepatology
- Vol. 84 (2) , 370-384
Targeting cell-state plasticity driven by FOXM1/CEBPB axis disrupts developmental heterogeneity and therapeutic resistance in hepatocellular carcinoma
- Open Access
- 17 April 2025
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 19 (8) , 101518
Decreasing Proprotein Convertase 5 Causes Hirschsprung’s Disease by Disrupting Neural Crest Cell Migration
- 17 April 2025
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 19 (8) , 101518
Open AccessDecreasing Proprotein Convertase 5 Causes Hirschsprung’s Disease by Disrupting Neural Crest Cell Migration
- Open Access
Ischemia promotes hypertrophic nerve trunk formation and enteric neuron cell death in Hirschsprung’s disease
Objective: Enteric nervous system dysfunction is linked to digestive and neurological disorders. Hirschsprung’s disease (HSCR) is characterized by the loss of enteric neuron cells (ENCs) in the distal colon. Embryonic enteric neural crest cell (ENCC) migration defects contribute to HSCR development in some infants, but postnatal factors that regulate ENC fate are undetermined. We sought to establish how postnatal changes contribute to HSCR by profiling the colonic microenvironment of HSCR infants. Design: In this study, we recruited infants with HSCR, infants with anorectal malformations but normal ENC development (CT), and a group of age-matched healthy control subjects. Laboratory findings and clinical manifestations were recorded. Single-cell and spatial transcriptome sequencing were applied to colonic tissues from a sub-cohort of CT and HSCR infants. Patient specimens, a mouse model of neonatal ischemic enterocolitis, and Sox10 knockdown mouse ( Sox10 WT/MUT ) were used to reveal the factors that lead to ENC loss in HSCR infants. Results: We discover that intestinal ischemia promotes CLDN1 + hypertrophic nerve trunk formation and ENC death. Mechanistically, ischemia leads to defective nitric oxide (NO) signaling in ENCs, which aggravates mitochondria damage and caspase-mediated apoptosis that can be ameliorated by a NO donor drug. Conclusion: We show that ischemia contributes to postnatal ENC loss in HSCR infants and suggest that NO donor drugs may alleviate ischemia-related ENC death.
Open AccessIschemia promotes hypertrophic nerve trunk formation and enteric neuron cell death in Hirschsprung’s disease
Objective: Enteric nervous system dysfunction is linked to digestive and neurological disorders. Hirschsprung’s disease (HSCR) is characterized by the loss of enteric neuron cells (ENCs) in the distal colon. Embryonic enteric neural crest cell (ENCC) migration defects contribute to HSCR development in some infants, but postnatal factors that regulate ENC fate are undetermined. We sought to establish how postnatal changes contribute to HSCR by profiling the colonic microenvironment of HSCR infants. Design: In this study, we recruited infants with HSCR, infants with anorectal malformations but normal ENC development (CT), and a group of age-matched healthy control subjects. Laboratory findings and clinical manifestations were recorded. Single-cell and spatial transcriptome sequencing were applied to colonic tissues from a sub-cohort of CT and HSCR infants. Patient specimens, a mouse model of neonatal ischemic enterocolitis, and Sox10 knockdown mouse ( Sox10 WT/MUT ) were used to reveal the factors that lead to ENC loss in HSCR infants. Results: We discover that intestinal ischemia promotes CLDN1 + hypertrophic nerve trunk formation and ENC death. Mechanistically, ischemia leads to defective nitric oxide (NO) signaling in ENCs, which aggravates mitochondria damage and caspase-mediated apoptosis that can be ameliorated by a NO donor drug. Conclusion: We show that ischemia contributes to postnatal ENC loss in HSCR infants and suggest that NO donor drugs may alleviate ischemia-related ENC death.
- Open Access
- 11 August 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1215473
Associated congenital heart disease with Hirschsprung's disease: a retrospective cohort study on 2,174 children
Objective: To examine the incidence and phenotypes of congenital heart disease (CHD) in a large cohort of patients with Hirschsprung's disease (HSCR).Study design: Retrospective data review of children with HSCR between 2003 and 2020 was conducted at the Provincial Key Laboratory for Structural Birth Defects in Guangzhou, Guangdong, China. HSCR was confirmed by pathological diagnosis. CHD was defined as a gross structural abnormality of the heart or intrathoracic great vessels that is of functional significance.Results: A total of 2,174 HSCR patients (84.7% males) were studied and 306 of them underwent echocardiography. Overall, 27 children (1.2%) had associated CHD. Among them, CHDs mostly presented as atrial and ventricular septal defects (n = 5 and 12 respectively) and patent ductus arteriosus (n = 4). Three patients (1.4‰) presented as a severe CHD including complete atrioventricular canal, congenitally corrected transposition of the great arteries and double-outlet of right ventricle. Among 14 patients carrying a chromosomal abnormality, CHD was detected in 4 infants (28.6%), all being mild forms of septal defects.Conclusions: Some new and severe types of CHD were found in patients with HSCR. Patients with syndromic features had higher incidence of CHD.
- 11 August 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1215473
Open AccessAssociated congenital heart disease with Hirschsprung's disease: a retrospective cohort study on 2,174 children
Objective: To examine the incidence and phenotypes of congenital heart disease (CHD) in a large cohort of patients with Hirschsprung's disease (HSCR).Study design: Retrospective data review of children with HSCR between 2003 and 2020 was conducted at the Provincial Key Laboratory for Structural Birth Defects in Guangzhou, Guangdong, China. HSCR was confirmed by pathological diagnosis. CHD was defined as a gross structural abnormality of the heart or intrathoracic great vessels that is of functional significance.Results: A total of 2,174 HSCR patients (84.7% males) were studied and 306 of them underwent echocardiography. Overall, 27 children (1.2%) had associated CHD. Among them, CHDs mostly presented as atrial and ventricular septal defects (n = 5 and 12 respectively) and patent ductus arteriosus (n = 4). Three patients (1.4‰) presented as a severe CHD including complete atrioventricular canal, congenitally corrected transposition of the great arteries and double-outlet of right ventricle. Among 14 patients carrying a chromosomal abnormality, CHD was detected in 4 infants (28.6%), all being mild forms of septal defects.Conclusions: Some new and severe types of CHD were found in patients with HSCR. Patients with syndromic features had higher incidence of CHD.
- Open Access
- 17 July 2023
- Published by Springer Nature in Pediatric Research
- Vol. 94 (6) , 1935-1941
Establishment and identification of an animal model of Hirschsprung disease in suckling mice
Background: Hirschsprung disease (HSCR) is a congenital intestinal malformation. Previous HSCR animal model needs invasive operation on adult animal. The aim of this study is to establish an early-onset animal model which is consistent with the clinical manifestation of HSCR patients. Methods: The neonatal mice were randomly divided into the benzalkonium chloride (BAC) group, treated with BAC via enema, and the control group, treated with saline. Weight changes, excretion time of carmine, CT scan, hematoxylin-eosin staining and immunofluorescence staining were used to evaluate the effect of the model. Differentially expressed genes (DEGs) in the HSCR mice were analyzed by using DAVID 6.8 database and compared with DEGs from HSCR patients. Results: The weight of mice was lower and the excretion time of carmine was longer in the BAC group. Moreover, distal colon stenosis and proximal colon enlargement appeared in the BAC group. Neurons in the distal colon decreased significantly after 4 weeks of BAC treatment and almost disappeared completely after 12 weeks. Transcriptome profiling of the mouse model and HSCR patients is similar in terms of altered gene expression. Conclusions: An economical and reliable HSCR animal model which has similar clinical characteristics to HSCR patients was successfully established. Impact: The animal model of Hirschsprung disease was first established in BALB/c mice. This model is an animal model of early-onset HSCR that is easy to operate and consistent with clinical manifestations. Transcriptome profiling of the mouse model and HSCR patients is similar in terms of altered gene expression.
- 17 July 2023
- Published by Springer Nature in Pediatric Research
- Vol. 94 (6) , 1935-1941
Open AccessEstablishment and identification of an animal model of Hirschsprung disease in suckling mice
Background: Hirschsprung disease (HSCR) is a congenital intestinal malformation. Previous HSCR animal model needs invasive operation on adult animal. The aim of this study is to establish an early-onset animal model which is consistent with the clinical manifestation of HSCR patients. Methods: The neonatal mice were randomly divided into the benzalkonium chloride (BAC) group, treated with BAC via enema, and the control group, treated with saline. Weight changes, excretion time of carmine, CT scan, hematoxylin-eosin staining and immunofluorescence staining were used to evaluate the effect of the model. Differentially expressed genes (DEGs) in the HSCR mice were analyzed by using DAVID 6.8 database and compared with DEGs from HSCR patients. Results: The weight of mice was lower and the excretion time of carmine was longer in the BAC group. Moreover, distal colon stenosis and proximal colon enlargement appeared in the BAC group. Neurons in the distal colon decreased significantly after 4 weeks of BAC treatment and almost disappeared completely after 12 weeks. Transcriptome profiling of the mouse model and HSCR patients is similar in terms of altered gene expression. Conclusions: An economical and reliable HSCR animal model which has similar clinical characteristics to HSCR patients was successfully established. Impact: The animal model of Hirschsprung disease was first established in BALB/c mice. This model is an animal model of early-onset HSCR that is easy to operate and consistent with clinical manifestations. Transcriptome profiling of the mouse model and HSCR patients is similar in terms of altered gene expression.